Eligible AACR 2018 Annual Meeting Registrants will be sent access information after the Annual Meeting

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 225
Opening Video
Opening Remarks
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
Tribute to Lydia Rodriguez, Assistant Director of Information Technology and Services, for 25 Years of Service to the AACR
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Introduction of AACR President
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Michael A. Caligiuri
The City of Hope National Medical Center, Duarte, California
Twelfth Annual AACR Team Science Award Presentation
Recipients: Genomic Approaches to Preventing and Treating Asian-Prevalent Cancers Team
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Recognition of the Fellows of the AACR Academy and Announcement of Fellows Governance
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the AACR June L. Biedler Prizes for Cancer Journalism
Recipients: David Crow, Esther Landhuis, Natasha Loder, Swagata Yadavar, Jay Korff, Carey Goldberg
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the 2018 AACR Distinguished Award for Extraordinary Scientific Achievement and Leadership in Breast Cancer Research
Recipient: C. Kent Osborne
Co-director, San Antonio Breast Cancer Symposium
Baylor College of Medicine, Houston, TX
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the AACR Award for Lifetime Achievement in Cancer Research
Recipient: Joseph R. Bertino
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Announcement of a New Strategic International Alliance between the AACR and Cancer Research UK
Michael A. Caligiuri
AACR President
Charles Swanton
Chief Clinician, Cancer Research UK
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Scientist↔Survivor Program: Twentieth Anniversary Video
Presentation of the 2018 AACR Distinguished Award for Exceptional Leadership in Cancer Science Policy and Advocacy
Recipient: Anna D. Barker, Arizona State University, Tempe, AZ
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the AACR 2018 Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy
Recipient: Col. (Ret.) James E. Williams, Alliance for Prostate Cancer Prevention, Camp Hill, PA
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Announcement of Major Gifts to Support Grants and Fellowships
Funders:
Johnson & Johnson Lung Cancer Initiative
AstraZeneca and MedImmune
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Recipient: Isaiah J. Fidler, University of Texas MD Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Announcement of AACR Partnership with UBS Oncology Impact Fund managed by MPM Capital: AACR-MPM Transformative Cancer Research Grants Program
Michael A. Caligiuri
AACR President
Christiana Bardon
Managing Director, MPM Capital
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Presentation of the 2018 AACR Distinguished Award for Extraordinary Scientific Innovation and Exceptional Leadership in Cancer Research and Biomedical Science
Recipient: Phillip A. Sharp, Massachusetts Institute of Technology, Cambridge, MA
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Closing Remarks
Michael A. Caligiuri
The City of Hope National Medical Center, Duarte, California
from AACR Annual Meeting 2018 on April 15, 2018 8:00 AM-9:30 AM
Introduction
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Liquid biopsy: Novel technologies and clinical applications
Klaus Pantel
University Medical Ctr. Hamburg, Hamburg, Germany
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
Alexander M Eggermont
Gustave Roussy Cancer Campus Grand Paris & University Paris-Saclay, Villejuif, France
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Discussant
Antoni Ribas
UCLA Medical Ctr., Los Angeles, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Mobilizing immunity against ovarian cancer
George Coukos
Ludwig Center for Cancer Research- University of Lausanne, Lausanne, Switzerland
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Cancer chromosome evolution in metastases, immune evasion, adaptation and clinical outcome: Insights from the TRACERx studies
Charles Swanton
The Francis Crick Institute and UCL Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Opportunities/Challenges for the Future
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase II PURE-01 study
Andrea Necchi
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
from AACR Annual Meeting 2018 on April 15, 2018 12:45 PM-2:50 PM
Discussant
James L Gulley
National Cancer Inst., Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 12:45 PM-2:50 PM
Front-line therapy of DIPG using the IDO pathway inhibitor indoximod in combination with radiation and chemotherapy
Theodore S Johnson
Georgia Cancer Center, Augusta University, Augusta, GA, United States
from AACR Annual Meeting 2018 on April 15, 2018 12:45 PM-2:50 PM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 225